MARKET WIRE NEWS
  1. Home
  2. Stock
  3. MSCL:CC
  4. News
Investor Relations
MSCL:CC
Quote
Short
News
Articles
Message Board

Satellos Bioscience Inc. (TSXVC : MSCL:CC ) News

News Releases

MSCL:CC News Releases
MSCL:CC : TSXVC
GlobeNewswire
Satellos Reports Six-Month Interim TRAILHEAD Data Showing Reduced Muscle Fat Fraction, Increased Effort, Stable Strength, Lower CK and Favorable Safety Profile in DMD Adults Treated with SAT-3247
MSCL:CC : TSXVC
GlobeNewswire
Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy
MSCL:CC : TSXVC
GlobeNewswire
Satellos to Present Clinical Program Updates at ICNMD 2026
MSCL:CC : TSXVC
GlobeNewswire
Satellos Bioscience Announces Results of Annual Meeting of Shareholders
MSCL:CC : TSXVC
SeekingAlpha
Satellos Bioscience GAAP EPS of -$0.53 misses by $0.01
MSCL:CC : TSXVC
GlobeNewswire
Satellos Reports First Quarter 2026 Financial Results and Highlights Company Progress
MSCL:CC : TSXVC
Investing News Network
5 Best-performing Canadian Pharma Stocks in 2026
MSCL:CC : TSXVC
GlobeNewswire
Satellos to Present at the Bloom Burton & Co. Healthcare Investor Conference
MSCL:CC : TSXVC
GlobeNewswire
Satellos Reports 2025 Financial Results and Highlights Recent Company Progress
MSCL:CC : TSXVC
GlobeNewswire
Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.